The Angioedema Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the Angioedema Treatment market has significantly increased in the recent past. The market which stood at $2.72 billion in 2024 is expected to reach $3.13 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 15.0%.
By 2029, the angioedema treatment market is projected to grow to a size of $5.4 billion. This impressive growth is expected to occur at a compound annual growth rate (CAGR) of 14.6%.
Download Your Free Sample of the 2025 Angioedema Treatment Market Report and Uncover Key Trends Now!The angioedema treatment market covered in this report is segmented –
1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema
2) By Route Of Administration: Injection, Oral
3) By End Use: Hospitals, Clinics, Research Organizations
The key drivers in the angioedema treatment marketare:
• Rising healthcare expenditure globally
• Enhanced awareness and understanding of allergies
• A growing prevalence of chronic health conditions
• Increased incidence of angioedema and emphasis on personalized medicine
The key trends in the angioedema treatment market are:
• Diagnostic technology advancements are a significant trend.
• Integration of machine learning is becoming increasingly popular.
• Investment in research and development is an emerging trend.
• There is a growing trend towards telemedicine and faster regulatory approvals for market access.
Major companies in the angioedema treatment market are:
• Sanofi SA
• Takeda Pharmaceutical Company Limited
• Viatris Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Fresenius Kabi AG
• Bausch Health Companies Inc.
• Apotex Inc.
• Aurobindo Pharma Ltd.
• Dr. Reddy’s Laboratories Ltd
• Cipla Inc.
• Alnylam Pharmaceuticals Inc
• Ionis Pharmaceuticals Inc.
• Salix Pharmaceuticals Ltd
• BioCryst Pharmaceuticals Inc.
• Pharming Group NV
• Pharvaris Netherlands B.V
• Astria Therapeutics
• Intellia Therapeutics
• KalVista Pharmaceuticals Ltd.
• ADARx Pharmaceuticals
• Adverum Biotechnologies Inc.
North America was the largest region in the angioedema treatment market in 2024